SCHEDULE 13G
Statement of Beneficial Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000919574-25-000110
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X01/primary_doc.xml…